Harbin Medical University - Tumor Hospital The Third Affiliated Hospital

Harbin 150081

0 studies enrolling now · 2 studies all time

What they study most

EGFR Exon 19 Deletion, EGFR L858R, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor, Nonsquamous Non-small Cell Lung Cancer

Studies at this site

• HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer — Running, not enrolling
• HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy — Running, not enrolling